| Primary |
| Bladder Cancer |
65.4% |
| Carcinoma In Situ Of Bladder |
8.9% |
| Product Used For Unknown Indication |
6.8% |
| Transitional Cell Carcinoma |
2.6% |
| Bladder Cancer Recurrent |
2.6% |
| Drug Use For Unknown Indication |
2.3% |
| Bladder Transitional Cell Carcinoma |
2.0% |
| Hypertension |
1.8% |
| Immunisation |
0.9% |
| Type 2 Diabetes Mellitus |
0.9% |
| Bladder Cancer Stage 0, With Cancer In Situ |
0.8% |
| Urinary Tract Carcinoma In Situ |
0.8% |
| Carcinoma In Situ |
0.7% |
| Malignant Neoplasm Of Renal Pelvis |
0.7% |
| Ureteric Cancer |
0.6% |
| Prophylaxis |
0.5% |
| Atrial Fibrillation |
0.5% |
| Hypercholesterolaemia |
0.5% |
| Benign Prostatic Hyperplasia |
0.4% |
| Depression |
0.4% |
|
| Pyrexia |
30.5% |
| Reiter's Syndrome |
10.1% |
| Pollakiuria |
9.0% |
| Bovine Tuberculosis |
5.6% |
| Tuberculosis |
5.5% |
| Urinary Tract Infection |
4.2% |
| Vomiting |
3.5% |
| Haematuria |
3.3% |
| White Blood Cell Count Increased |
3.0% |
| Cystitis |
2.7% |
| Orchitis |
2.5% |
| Sepsis |
2.5% |
| Contracted Bladder |
2.4% |
| Pyuria |
2.4% |
| Urinary Retention |
2.4% |
| Prostatitis |
2.3% |
| Septic Shock |
2.1% |
| Disseminated Tuberculosis |
2.0% |
| Interstitial Lung Disease |
2.0% |
| Renal Impairment |
2.0% |
|
| Secondary |
| Bladder Cancer |
56.2% |
| Carcinoma In Situ Of Bladder |
10.1% |
| Transitional Cell Carcinoma |
3.6% |
| Product Used For Unknown Indication |
3.5% |
| Bladder Cancer Recurrent |
3.2% |
| Antibiotic Prophylaxis |
2.3% |
| Bladder Transitional Cell Carcinoma |
1.9% |
| Epididymitis |
1.9% |
| Hypertension |
1.9% |
| Convulsion |
1.8% |
| Infection Prophylaxis |
1.8% |
| Depression |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Malignant Neoplasm Of Renal Pelvis |
1.4% |
| Ureteric Cancer |
1.4% |
| Drug Use For Unknown Indication |
1.3% |
| Urinary Tract Carcinoma In Situ |
1.3% |
| Atrial Fibrillation |
1.0% |
| Urinary Bladder Polyp |
0.8% |
|
| Pyrexia |
27.5% |
| Urinary Tract Infection |
9.0% |
| Pollakiuria |
7.3% |
| Pyuria |
6.1% |
| White Blood Cells Urine Positive |
5.8% |
| Vomiting |
5.1% |
| White Blood Cell Count Increased |
4.6% |
| Oxygen Saturation Decreased |
3.4% |
| Septic Shock |
3.4% |
| Urine Abnormality |
3.2% |
| Restlessness |
2.9% |
| Cystitis |
2.7% |
| Epididymitis |
2.7% |
| Prostatitis |
2.7% |
| Scrotal Pain |
2.7% |
| Pain |
2.2% |
| Renal Impairment |
2.2% |
| Sepsis |
2.2% |
| Ureteritis |
2.2% |
| Urinary Bladder Haemorrhage |
2.2% |
|
